Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia ...

What recent reports has she seen on the economy? Rt Hon CHRIS HIPKINS to the Prime Minister: Does he stand by all his ...

In a placebo-controlled, randomised Phase Ib trial, the therapy demonstrated a 77% reduction in bacterial BSIs against ...

Without such a framework, the language risks continued fragmentation, inconsistent development, and limited functionality in ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

A new announcement from Crown Bank Dental Congleton confirms that the practice is now accepting bookings for private patient ...

Nearly 25 years ago waste management comapany Indaver applied for planning permission a hazardous and non-hazardous waste incinerator at Ringaskiddy, County Cork.  This was refused permission by Cork ...

Recent headlines about acetaminophen use during pregnancy have left many expectant families feeling anxious, but experts say ...

South Rampart Pharma is working to develop an oral small molecule non-opioid pain treatment which has generated early positive clinical data as a therapy for acute and chronic pain, as well as ...

In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

In today’s ACT Brief, we explore how Eli Lilly’s orforglipron could become the first oral GLP-1 therapy reviewed under FDA’s new national priority program, and examine emerging regulatory and ethical ...